Head-to-head comparisons of medication uses, side effects, warnings, and more.
Arexvy (RSV vaccine)
Abrysvo (RSV vaccine)
Arexvy (RSV vaccine)
Abrysvo (RSV vaccine)
Summary of Arexvy vs. Abrysvo
Summary for Vaccine
Prescription only
Arexvy (RSV vaccine) is a FDA-approved vaccine used to lower the risk of illness caused by respiratory syncytial virus (RSV). It's the first RSV vaccine approved in the United States. You can receive Arexvy (RSV vaccine) if you're age 60 years or older, and in some cases, starting at age 50 if you're at high risk for serious problems if infected. But first, you should discuss the risks and benefits with your primary care provider. Arexvy (RSV vaccine) is given once as a shot into the muscle, typically in your upper arm. Common side effects of this vaccine include injection site reactions, headache, joint and muscle aches, and feeling tired.
Summary for Vaccine
Prescription only
Abrysvo (RSV vaccine) is a bivalent vaccine used to lower the risk of illness caused by respiratory syncytial virus (RSV). It's FDA-approved for adults ages 60 years and older, and adults who are between 32 and 36 weeks of pregnancy to protect babies during the first 6 months of life. Abrysvo (RSV vaccine) is given as an injection into the muscle and can cause tiredness, headache, and pain at the injection site as side effects.